Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 OutbreakArticle Published on 2021-07-242022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Administered Anxiety biochemical biologics clinical conducted Contact coronavirus disease COVID-19 COVID-19 infection COVID-19 outbreak Crohn’s disease demonstrated drug drugs group HADS hospital Hospital admission hospitalisation Hospitalized IBD immunomodulatory therapy Implications in both group increase Infection Inflammatory bowel disease infusion intravenous investigated Level lockdown pandemic Patient patients treated performed questionnaire receiving recruited Relapse risk risk of COVID-19 risk of infection Satisfaction scale significantly lower Symptom therapy treated ulcerative colitis were recorded [DOI] 10.3390/jcm10153270 PMC 바로가기 [Article Type] Article
Unravelling the Phytochemical Composition and the Pharmacological Properties of an Optimized Extract from the Fruit from Prunus mahaleb L.: From Traditional Liqueur Market to the Pharmacy ShelfArticle Published on 2021-07-222022-10-30 Journal: Molecules [Category] Coronavirus, SARS, [키워드] Prunus mahaleb L. ACE2 anti-bacterial effects anti-COVID-19 effects antimicrobial Bacterial blunting cells chicoric acid clinical symptom Colon downregulation Effect Effects Extract fruit Gene Expression gram H1299 human host in vitro indicate inhibit SARS-CoV-2 investigated Liqueur Local lung adenocarcinoma neuroprotection Pharmacy phenolic profile phytochemical property Protective effects Prunus mahaleb reducing scavenging shelf Strains Support tested TMPRSS2 TNFα Traditional Treatment ulcerative colitis VEGFA virus entry was measured [DOI] 10.3390/molecules26154422 PMC 바로가기 [Article Type] Article
Viral infections in inflammatory bowel disease: Tips and tricks for correct managementReview Published on 2021-07-212024-09-02 Journal: World journal of gastroenterology [Category] 대상포진, [키워드] Crohn’s disease inflammatory bowel diseases opportunistic Infections Standard of care ulcerative colitis viral infections [DOI] 10.3748/wjg.v27.i27.4276 PMC 바로가기 [Article Type] Review
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE StudyOriginal Article Published on 2021-07-132024-09-04 Journal: Journal of Crohn's and Colitis [Category] 대상포진, [키워드] clinical trial Ozanimod ulcerative colitis [DOI] 10.1093/ecco-jcc/jjab012 PMC 바로가기 [Article Type] Original Article
Recurrent COVID-19 in a Patient With Ulcerative Colitis on Vedolizumab Therapy베돌리주맙 요법을 받고 있는 궤양성 대장염 환자의 재발성 COVID-19Case Reports Published on 2021-07-052022-09-12 Journal: Journal of Crohn's & colitis [Category] 진단, [키워드] Abstract COVID-19 Recurrent ulcerative colitis vedolizumab [DOI] 10.1093/ecco-jcc/jjaa259 PMC 바로가기 [Article Type] Case Reports
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 20212021년 임상 실습에서 급성 중증 대장염-논란의 결과 예측Review Published on 2021-07-052022-09-11 Journal: Journal of Crohn's & colitis [Category] 바이오마커, [키워드] accelerated Acute severe colitis Admission Biomarker Biomarkers calprotectin Care Ciclosporin clinical Clinical practice colectomy Colitis Corticosteroid Corticosteroids COVID-19 pandemic criteria cut-off defined development disease course endoscopy following implication include infliximab initial machine management medical emergency morbidity and mortality multi multiomics outcome Patient point-of-care Practice predict predictor Prognosis radiological rescue therapy Research risk risk stratification role serum serum biomarkers Specific therapy to define true love and witts. ulcerative colitis X-ray [DOI] 10.1093/ecco-jcc/jjaa265 PMC 바로가기 [Article Type] Review
Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infectionSARS-COV-2 감염의 맥락에서 염증성 장 질환의 병인Review Published on 2021-07-012022-09-12 Journal: Molecular biology reports [Category] SARS, 진단, [키워드] ACE2 receptor Activation Adaptive immune response adaptive immune responses Adaptive immunity alveolar epithelial cells binding bowel carried Colitis consequence coronavirus COVID-19 Critical Crohn’s disease entry of SARS-CoV-2 expression Extracellular Factors gastrointestinal tract Genetic predisposition Host host cell IBD immune response increase in individual induce infecting Infection infection with SARS-CoV-2 Inflammation Inflammatory bowel disease inflammatory reaction initiate Innate Innate immunity intestinal intestinal enterocyte intestinal tissue molecular new SARS-CoV-2 pathway Patient patients proinflammatory cytokines receptor Research risk SARS-CoV-2 SARS-COV-2 infection Toll-like receptors ulcerative colitis virus [DOI] 10.1007/s11033-021-06565-w PMC 바로가기 [Article Type] Review
Small Molecule Drugs in Inflammatory Bowel DiseasesReview Published on 2021-06-302024-09-02 Journal: Pharmaceuticals [Category] 대상포진, [키워드] Crohn’s disease inflammatory bowel diseases small molecule drugs ulcerative colitis [DOI] 10.3390/ph14070637 PMC 바로가기 [Article Type] Review
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme궤양성 대장염 치료를 위한 토파시티닙: 궤양성 대장염 임상 프로그램의 감염률 분석Randomized Controlled Trial Published on 2021-06-222023-06-01 Journal: Journal of Crohn's & colitis [Category] 대상포진, 두창, 수두, 홍역, [키워드] infections Tofacitinib ulcerative colitis [DOI] 10.1093/ecco-jcc/jjaa233 PMC 바로가기 [Article Type] Randomized Controlled Trial
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS StudyOriginal Article Published on 2021-06-212024-09-04 Journal: Journal of Crohn's and Colitis [Category] 대상포진, [키워드] etrasimod Long-term extension study ulcerative colitis [DOI] 10.1093/ecco-jcc/jjab016 PMC 바로가기 [Article Type] Original Article